Innovating Works

Cellzome

Desconocido
OVER-MYR: Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes... CELLZOME AG participó en un FP7: Multiple Myeloma (MM) is a currently incurable rare malignant plasma cell disease, which invariably relapses despite therapy. The objective...
Financiado
ORCHID: Open Collaborative Model for Tuberculosis Lead Optimisation CELLZOME AG participó en un FP7: "Early stage Drug Discovery efforts over the last 5 years have resulted in the identification of a number of promising lead compounds in the...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.